<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04122664</url>
  </required_header>
  <id_info>
    <org_study_id>265864</org_study_id>
    <nct_id>NCT04122664</nct_id>
  </id_info>
  <brief_title>Posterior Capsular Opacification and Glistenings in Hydrophobic and Hydrophilic Intraocular Lenses</brief_title>
  <official_title>Prospective Randomized Controlled Study Measuring Posterior Capsular Opacification, Lens Glistenings, Tilt and Decentration, and Visual Outcomes Following Insertion of the RayOne Hydrophobic Lens 800C and the RayOne Hydrophilic Lens 600C.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>City, University of London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective randomized controlled clinical study to measure posterior capsular
      opacification, objective measurement of glistenings and intraocular lens tilt and
      decentration as well as visual outcomes following insertion of a monofocal, aspheric,
      hydrophobic acrylic intraocular lens: the RayOne® Hydrophobic lens 800C and a monofocal
      aspheric, hydrophilic acrylic intraocular lens: the RayOne® Hydrophilic lens 600C
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 14, 2019</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients randomised into one of two groups</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Posterior Capsular Opacification of Intraocular Lens</measure>
    <time_frame>24 months</time_frame>
    <description>Degree of the Posterior Capsular Opacification of Intraocular Lens will be assessed using digital imaging techniques</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular lens glistenings</measure>
    <time_frame>24 months</time_frame>
    <description>Degree of the intraocular lens glistenings will be quantified using digital analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular lens tilt and decentration</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Acuities</measure>
    <time_frame>24 months</time_frame>
    <description>Unaided and Best corrected Logmar Visual acuity for distance, and for near vision will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forward light scatter and Contrast Sensitivity Measurement</measure>
    <time_frame>24 months</time_frame>
    <description>Forward light scatter and Contrast Sensitivity Measurement will be quantified using computerised visual testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>24 months</time_frame>
    <description>Validated questionnaires will be used to assess patient satisfaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative and post operative complications</measure>
    <time_frame>0 days-24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">176</enrollment>
  <condition>Cataract</condition>
  <condition>Intraocular Lens Opacification</condition>
  <arm_group>
    <arm_group_label>RayOne® Hydrophilic lens 600C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be randomly selected to receive the monofocal, acrylic, RayOne® Hydrophilic lens 600C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RayOne® Hydrophobic lens 800C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be randomly selected to receive the monofocal, acrylic, RayOne® Hydrophobic lens 800C</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RayOne® Hydrophobic lens 800C</intervention_name>
    <description>Patients will receive a monofocal, aspheric, hydrophobic acrylic intraocular lens: the RayOne® Hydrophobic lens 800C</description>
    <arm_group_label>RayOne® Hydrophobic lens 800C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RayOne® Hydrophilic lens 600C</intervention_name>
    <description>Patients will receive a monofocal aspheric, hydrophilic acrylic intraocular lens: the RayOne® Hydrophilic lens 600C.</description>
    <arm_group_label>RayOne® Hydrophilic lens 600C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Unilateral or bilateral cataracts requiring surgical intervention

          2. Age over 18 years

          3. Able to understand informed consent and the objectives of the trial

          4. Not pregnant, not breast feeding

          5. No previous eye surgery

          6. Corneal astigmatism less than 1 diopter in both eyes.

        Exclusion Criteria:

          1. age-related macula degeneration

          2. glaucoma

          3. previous retinal vascular disorders

          4. previous retinal detachment or tear

          5. any neuro-ophthalmological condition

          6. any inherited retinal disorder or pathology

          7. previous strabismus surgery or record of amblyopia

          8. previous TIA, CVA or other vaso-occlusive disease

          9. already enrolled in another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Khayam Naderi, MBBS BSc MA</last_name>
    <phone>020 7188 7188</phone>
    <phone_ext>84331</phone_ext>
    <email>khayam.naderi@gstt.nhs.uk</email>
  </overall_contact>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 8, 2019</study_first_submitted>
  <study_first_submitted_qc>October 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>October 9, 2019</last_update_submitted>
  <last_update_submitted_qc>October 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Capsule Opacification</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

